CancerIQ Joins CancerX Moonshot Initiative
I’m incredibly proud that CancerIQ is officially a member of the CancerX Moonshot initiative, an innovative partnership led by the Digital Medicine...
I’m incredibly proud that CancerIQ is officially a member of the CancerX Moonshot initiative, an innovative partnership led by the Digital Medicine...
How NCCN Guidelines and the Tyrer-Cuzick Lifetime Model differ and why programs are missing patients.
OSF HealthCare, one of our longstanding partners, recently enhanced their program with a hybrid HL7 and FHIR integration with CancerIQ to integrate...
The changing season is the perfect time for health systems to upgrade their screening programs to support cancer prevention and early detection...
The average breast program provides one-size-fits-all preventive care that fails to meet the needs of the 1 in 10 women, like Jill Martin, with the...
The time for bigger and bolder is now, and we are humbled by the potential impact CancerIQ can have on patients and their families in the next...
At ASCO, I saw a lot of new innovations that are accelerating the urgency to change how we think about genomics in cancer prevention and treatment.
Our latest offerings underscore our commitment to the genetics community, high-risk program outcomes, and continued innovation in precision...
This year we were excited to see growing momentum around personalized prevention & early detection of cancer. Read on for our top 3 three takeaways...
Your curated February 2023 articles from trusted sources, keeping you up-to-date on cancer prevention, precision medicine & oncology, health equity,...